Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients
暂无分享,去创建一个
S. Yusuf | K. Sliwa | E. Lonn | M. Böhm | R. Schmieder | P. Sleight | F. Mahfoud | T. Unger | G. Mancia | H. Schumacher | J. Pöss | Teo Koon | M. Kratz | M. T. Kratz | M. Böhm
[1] M. Martínez-González,et al. Adherence to the Mediterranean dietary pattern and heart rate in the SUN project , 2014, European journal of preventive cardiology.
[2] S. Yusuf,et al. Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. , 2012, European heart journal.
[3] M. Böhm,et al. Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: data from I-SEARCH , 2012, European journal of preventive cardiology.
[4] R. Düsing. Sexual Dysfunction in Male Patients with Hypertension , 2012, Drugs.
[5] M. Endres,et al. Heart Rate Contributes to the Vascular Effects of Chronic Mental Stress: Effects on Endothelial Function and Ischemic Brain Injury in Mice , 2011, Stroke.
[6] M. Böhm,et al. Cardiovascular risk, drugs and erectile function – a systematic analysis , 2011, International journal of clinical practice.
[7] U. Laufs,et al. Vascular pathophysiology in response to increased heart rate. , 2010, Journal of the American College of Cardiology.
[8] Michael Böhm,et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial , 2010, The Lancet.
[9] U. Laufs,et al. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. , 2010, Atherosclerosis.
[10] I. Abidin. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomized placebo-controlled trial , 2010 .
[11] S. Yusuf,et al. Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONT , 2010, Circulation.
[12] M. Böhm,et al. Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. , 2009, European heart journal.
[13] S. Yusuf,et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial , 2008, The Lancet.
[14] M. Böhm,et al. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome , 2008, International Journal of Impotence Research.
[15] M. Böhm,et al. Nebivolol, but Not Metoprolol, Improves Endothelial Function of the Corpus Cavernosum in Apolipoprotein E-Knockout Mice , 2008, Journal of Pharmacology and Experimental Therapeutics.
[16] A. Kong,et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. , 2008, Journal of the American College of Cardiology.
[17] C. Gazzaruso,et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. , 2008, Journal of the American College of Cardiology.
[18] R. Kloner. Erectile dysfunction: the new harbinger for major adverse cardiac events in the diabetic patient. , 2008, Journal of the American College of Cardiology.
[19] U. Laufs,et al. Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice , 2008, Circulation.
[20] W. Ahmad. Effect of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomized controlled trial: The Telmisartan Randomised Assessment Study in ACE intolerant subjects with cardiovascular Disease (TRANSCEND) , 2008 .
[21] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.
[22] M. Böhm,et al. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH , 2008, Journal of hypertension.
[23] C. Pepine,et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). , 2007, European heart journal.
[24] R. Collins,et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.
[25] S. Yusuf,et al. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-IN , 2007, American heart journal.
[26] Jean-Claude Tardif,et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. , 2005, European heart journal.
[27] K. Billups. Endothelial dysfunction as a common link between erectile dysfunction and cardiovascular disease , 2004 .
[28] R. Marfella,et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. , 2004, JAMA.
[29] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[30] J. Bermejo,et al. Portable spectral Doppler echocardiographic device: overcoming limitations , 2003, Heart.
[31] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[32] R. Kloner,et al. Erectile dysfunction and atherosclerosis , 2002, Current atherosclerosis reports.
[33] W. Hop,et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. , 2001, Urology.
[34] T. H. Klotz,et al. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’ , 2000, International Journal of Impotence Research.
[35] C. Lewis,et al. Long-Term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS) , 1998 .
[36] Michael Böhm,et al. Heart rate reduction in cardiovascular disease and therapy , 2010, Clinical Research in Cardiology.
[37] D. Coplen. Erectile Dysfunction and Subsequent Cardiovascular Disease , 2006 .
[38] R. Düsing. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. , 2005, Drugs.
[39] C. Lewis,et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) , 1997, Hypertension.